MaxCyte Inc (LON:MXCT) insider Stark Thompson sold 24,000 shares of the stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of GBX 246 ($3.40), for a total value of £59,040 ($81,569.49).
MaxCyte Inc (LON:MXCT) traded down GBX 1.67 ($0.02) during mid-day trading on Wednesday, hitting GBX 247.33 ($3.42). The stock has a market capitalization of $261.77 and a PE ratio of -2,473.30. MaxCyte Inc has a 52 week low of GBX 225 ($3.11) and a 52 week high of GBX 305 ($4.21).
TRADEMARK VIOLATION WARNING: “Stark Thompson Sells 24,000 Shares of MaxCyte Inc (MXCT) Stock” was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/3228478/stark-thompson-sells-24000-shares-of-maxcyte-inc-mxct-stock.html.
MaxCyte, Inc focuses on cell-based medicines. The Company’s cell modification technology, Flow electroporation, is used for discovery, development and manufacture of small molecule, biologic and cell-based therapeutics. The Company’s products include instruments, processing assemblies and insourcing services.
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.